• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Financial Officer Buckhalter Matthew was granted 139,665 shares and covered exercise/tax liability with 51,298 shares, increasing direct ownership by 21% to 501,245 units (SEC Form 4)

    6/9/25 7:00:29 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Buckhalter Matthew

    (Last) (First) (Middle)
    C/O AVEANNA HEALTHCARE HOLDINGS INC.
    400 INTERSTATE NORTH PARKWAY SE

    (Street)
    ATLANTA GA 30339

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Aveanna Healthcare Holdings, Inc. [ AVAH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    06/05/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 per share 06/05/2025 A 139,665(1) A $0 552,543 D
    Common Stock, par value $0.01 per share 06/05/2025 F 51,298(2) D $5.51 501,245 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's Senior Management Retention Plan.
    2. Represents shares withheld for payment of taxes upon vesting of performance-based restricted stock units; not an open market transaction.
    /s/ Jonathan Beckler, Attorney-in-Fact 06/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AVAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    11/21/2022$7.00 → $3.00Outperform → Sector Perform
    RBC Capital Mkts
    11/17/2022$5.50 → $2.00Outperform → Neutral
    Credit Suisse
    7/22/2022$2.50Buy → Hold
    Jefferies
    7/5/2022Buy → Hold
    Truist
    More analyst ratings

    $AVAH
    SEC Filings

    See more
    • SEC Form 144 filed by Aveanna Healthcare Holdings Inc.

      144 - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      6/10/25 4:09:18 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Amendment: Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K/A - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      6/4/25 7:30:08 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form 424B7 filed by Aveanna Healthcare Holdings Inc.

      424B7 - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/23/25 4:06:17 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aveanna downgraded by JP Morgan

      JP Morgan downgraded Aveanna from Neutral to Underweight

      12/13/23 6:49:11 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • UBS initiated coverage on Aveanna with a new price target

      UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50

      11/30/23 7:52:45 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna downgraded by Raymond James

      Raymond James downgraded Aveanna from Strong Buy to Mkt Perform

      5/12/23 7:24:50 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Compliance Officer Cunningham Patrick A. sold $91,174 worth of shares (18,500 units at $4.93), decreasing direct ownership by 5% to 327,869 units (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      6/13/25 7:00:07 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner J.H. Whitney Equity Partners Vii, Llc sold $3,900,000 worth of shares (750,000 units at $5.20) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      6/12/25 11:45:52 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Vigano Paul R sold $3,900,000 worth of shares (750,000 units at $5.20) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      6/12/25 11:43:46 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aveanna Healthcare Holdings Completes Acquisition of Thrive Skilled Pediatric Care

      ATLANTA, June 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it completed its acquisition of Thrive Skilled Pediatric Care, LLC ("Thrive SPC"). Thrive SPC is one of the largest independent providers of pediatric home care with 23 locations in seven states including Arizona, Georgia, Kansas, New Mexico, North Carolina, Virginia, and Texas. Thrive SPC primarily provides skilled Private Duty Nursing services, but also provides Pediatric Therapy, Licensed Health Aide Services, and Certified Nurse Assistant Services. The com

      6/4/25 7:30:26 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the RBC 2025 Global Healthcare Conference

      ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquart

      4/29/25 7:30:32 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care